XPENG (NYSE:XPEV - Get Free Report) was downgraded by stock analysts at BNP Paribas Exane from a "neutral" rating to an "underperform" rating in a report issued on Wednesday, Marketbeat reports.
A number of other analysts have also recently commented on the company. Barclays lowered their price target on XPENG from $17.00 to $16.00 and set an "underweight" rating for the company in a research note on Tuesday, March 24th. Loop Capital set a $25.00 price target on XPENG in a research note on Tuesday, January 6th. Morgan Stanley reaffirmed a "reduce" rating on shares of XPENG in a research note on Monday, December 29th. Macquarie Infrastructure set a $26.00 price target on XPENG and gave the company an "outperform" rating in a research note on Thursday, January 15th. Finally, Citigroup reaffirmed a "buy" rating on shares of XPENG in a research note on Friday, February 6th. Two analysts have rated the stock with a Strong Buy rating, four have assigned a Buy rating, one has issued a Hold rating and four have given a Sell rating to the company. Based on data from MarketBeat.com, XPENG has an average rating of "Hold" and an average price target of $24.74.
Read Our Latest Report on XPEV
XPENG Stock Performance
XPENG stock opened at $17.19 on Wednesday. The company has a current ratio of 1.09, a quick ratio of 0.91 and a debt-to-equity ratio of 0.24. XPENG has a 1 year low of $15.38 and a 1 year high of $28.24. The company has a market cap of $16.32 billion, a PE ratio of -101.12 and a beta of 1.18. The company's 50-day moving average is $17.92 and its two-hundred day moving average is $19.82.
XPENG (NYSE:XPEV - Get Free Report) last released its earnings results on Sunday, February 15th. The company reported $0.04 earnings per share (EPS) for the quarter. The company had revenue of $3.18 billion for the quarter. XPENG had a negative net margin of 1.46% and a negative return on equity of 3.71%. Equities analysts anticipate that XPENG will post -0.16 earnings per share for the current year.
Institutional Trading of XPENG
A number of large investors have recently bought and sold shares of the business. EverSource Wealth Advisors LLC increased its stake in XPENG by 16.9% during the 3rd quarter. EverSource Wealth Advisors LLC now owns 2,694 shares of the company's stock worth $63,000 after purchasing an additional 389 shares in the last quarter. Parallel Advisors LLC increased its stake in XPENG by 6.0% during the 4th quarter. Parallel Advisors LLC now owns 10,293 shares of the company's stock worth $209,000 after purchasing an additional 584 shares in the last quarter. Greenleaf Trust increased its stake in XPENG by 4.7% during the 3rd quarter. Greenleaf Trust now owns 17,005 shares of the company's stock worth $398,000 after purchasing an additional 770 shares in the last quarter. SBI Securities Co. Ltd. increased its stake in XPENG by 7.7% during the 4th quarter. SBI Securities Co. Ltd. now owns 16,535 shares of the company's stock worth $335,000 after purchasing an additional 1,186 shares in the last quarter. Finally, Farther Finance Advisors LLC increased its stake in XPENG by 161.4% during the 4th quarter. Farther Finance Advisors LLC now owns 2,562 shares of the company's stock worth $52,000 after purchasing an additional 1,582 shares in the last quarter. 21.09% of the stock is owned by institutional investors.
About XPENG
(
Get Free Report)
XPENG Inc NYSE: XPEV is a China-based developer and manufacturer of smart electric vehicles. The company designs, engineers and sells battery-electric sedans and sport-utility vehicles along with related software and services. Founded in 2014, XPENG positions itself as a technology-driven automaker with a focus on vehicle connectivity, software-defined features and advanced driver assistance systems.
Product offerings center on passenger EVs spanning compact crossovers and midsize sedans, supported by in-house software platforms and over-the-air update capabilities.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider XPENG, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and XPENG wasn't on the list.
While XPENG currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.